Skip to main content

Table 4 Intraprocedural and post-procedural aspect during intervention

From: Long-term follow-up of therapeutic efficacy of everolimus-eluting bioresorbable vascular scaffold in comparison to everolimus-eluting stent in treatment of chronic total occlusion guided by intracoronary imaging

PCI DES group Absorb group Test p value Sig.
No. = 40 No. = 20
Artery LAD 18 (45.0%) 9 (45.0%) 0.000a 1.000 NS
RCA 18 (45.0%) 9 (45.0%)
LCX 4 (10.0%) 2 (10.0%)
Antegrade or retrograde Antegrade 30 (75.0%) 15 (75.0%) 0.000a 1.000 NS
Retrograde 10 (25.0%) 5 (25.0%)
J score Median (IQR) 3 (3 – 4) 3 (3–4) − 0.679c 0.497 NS
Range 3–4 2–4
Pre-dilatation Done 40 (100.0%) 20 (100.0%)
Post-dilatation Not done 2 (5.0%) 0 (0.0%) 1.034a 0.309 NS
Done 38 (95.0%) 20 (100.0%)
Stent length Mean ± SD 32.53 ± 9.46 29.40 ± 8.61 1.242b 0.219 NS
Range 15–48 18–38
DAPT Given 40 (100.0%) 20 (100.0%)
TIMI flow intraprocedure II 2 (5.0%) 0 (0.0%) 1.034a 0.309 NS
III 38 (95.0%) 20 (100.0%)
Coronary perforation occurred 0 (0%) 1 (0.05%) 0.000a 1.000 NS
  1. NS non-significant, S significant
  2. aChi-square test
  3. bIndependent t test
  4. cMann-Whitney test